Trial | NCT00566514  Report issue

Title

The Role of Ribose in Patients Diagnosed With Fibromyalgia
The Role of D-RIbose in Patients Diagnosed With Fibromyalgia

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Suspended

  • Study Participants

    200
The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.
Two hundred to three hundred subjects (equally distribued between placebo and D-ribose) between 18-78 years of age will comprise this study. The final numbers enrolled will depend upon obtaining approximately 100 subjects that can display a high degree of compliance to TID dosing with approximately equal balance between the active and placebo arms.
Study Started
Jul 31
2006
Primary Completion
Jul 31
2008
Anticipated
Study Completion
Jul 31
2008
Anticipated
Last Update
Mar 13
2008
Estimate

Dietary Supplement D-ribose

5 grams administered orally TID

  • Other names: Corvalen

Other dextrose

5 grams orally TID

1 Active Comparator

D-ribose 5 grams TID orally

2 Placebo Comparator

Dextrose 5 grams TID

Criteria 

Inclusion Criteria:

previous diagnosis of fibromomyalgia by a MD
Has been diagnosed with fibromyalgia and are over 18 years of age
Does live in the United States

Exclusion Criteria:

does NOT have severe medication/chemical/supplement sensitivities
does NOT have insulin dependent diabetes or other severe illnesses (cancer, hepatitis, congestive heart failure)
does NOT have rheumatoid arthritis or gout
previous use of ribose
No Results Posted